Polypharmacy

Polypharmacy is a clinical term for the concurrent use of multiple medications, commonly defined as five or more. It is a significant patient safety risk, especially among the elderly, as it increases the likelihood of adverse drug events and interactions. From a risk management perspective, the associated medication data is classified as 'special category data' under GDPR Article 9 and requires heightened protection. Any system processing this data must adhere to a Privacy Information Management System (PIMS) framework, such as ISO/IEC 27701, to manage risks of data breaches and ensure compliance with privacy regulations throughout the data lifecycle.

In enterprise risk management, particularly for healthcare organizations, addressing polypharmacy involves integrating clinical and privacy controls. Key steps include: 1) Risk Identification: Use clinical decision support systems to flag at-risk patients and conduct a Privacy Impact Assessment (PIA) per ISO/IEC 29134 on systems handling medication data. 2) Control Implementation: Deploy PIMS controls based on ISO/IEC 27701, such as data encryption, role-based access control, and staff training. 3) Monitoring & Review: Regularly audit access logs and track key metrics like 'privacy incidents related to medication data' (target: 0). A successful implementation can lead to measurable outcomes, such as a 15% reduction in adverse drug events and a 100% audit pass rate for data protection compliance.

Taiwan enterprises face three primary challenges: 1) Fragmented Health Data: Patients visit multiple providers, creating incomplete medication records. Solution: Integrate with Taiwan's National Health Insurance (NHI) PharmaCloud System to get a consolidated view, with patient consent. 2) Balancing Clinical Access and Privacy: Clinicians need rapid access, which can conflict with strict privacy controls. Solution: Implement role-based access with a 'break-the-glass' protocol for emergencies, where all actions are logged and audited. 3) Legacy IT Systems: Older systems often lack modern security features. Solution: Pursue a phased modernization plan, prioritizing the security of the medication database with compensating controls like database activity monitoring, while planning a full system upgrade.

Winners Consulting specializes in Polypharmacy for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact